492 related articles for article (PubMed ID: 16431284)
1. In vivo treatment of mice with heat shock protein, gp 96, improves survival of skin grafts with minor and major antigenic disparity.
Kovalchin JT; Mendonca C; Wagh MS; Wang R; Chandawarkar RY
Transpl Immunol; 2006 Jan; 15(3):179-85. PubMed ID: 16431284
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of portal venous tolerant long-term MHC Class I L(d)-specific skin graft survival in transgenic 2CF1 mice.
Margenthaler JA; Landeros K; Kataoka M; Flye MW
Transpl Immunol; 2003; 11(1):23-9. PubMed ID: 12727472
[TBL] [Abstract][Full Text] [Related]
3. Targeted gene disruption of the heat shock protein 72 gene (hsp70.1) in the donor tissue is associated with a prolonged rejection-free survival in the murine skin allograft model.
Oh KH; Kim JY; Kim D; Lee EM; Oh HY; Seo JS; Han JS; Kim S; Lee JS; Ahn C
Transpl Immunol; 2004 Dec; 13(4):273-81. PubMed ID: 15589740
[TBL] [Abstract][Full Text] [Related]
4. Specific tolerance induction of allo-K(b)-skin grafts by FK506 in the CD8-depleted H-2(k) recipients required low amounts of K(b)-antigen.
Chen BG; Liu Z; Wu Y
Transpl Immunol; 2005 Oct; 15(1):9-16. PubMed ID: 16223668
[TBL] [Abstract][Full Text] [Related]
5. The thymus is required for the ability of FTY720 to prolong skin allograft survival across different histocompatibility MHC barriers.
del Rio ML; Pabst O; Ramirez P; Penuelas-Rivas G; Förster R; Rodriguez-Barbosa JI
Transpl Int; 2007 Oct; 20(10):895-903. PubMed ID: 17854447
[TBL] [Abstract][Full Text] [Related]
6. Role of CD4+ and CD8+ T cells in murine skin and heart allograft rejection across different antigenic desparities.
Youssef AR; Otley C; Mathieson PW; Smith RM
Transpl Immunol; 2004 Dec; 13(4):297-304. PubMed ID: 15589743
[TBL] [Abstract][Full Text] [Related]
7. Effector mechanisms in murine allograft rejection: comparison of skin and heart grafts in fully allogeneic and minor histocompatibility antigen-mismatched strain combinations.
Youssef AR; Otley C; Mathieson PW; Smith RM
Transpl Int; 2002 Jun; 15(6):302-9. PubMed ID: 12072901
[TBL] [Abstract][Full Text] [Related]
8. Donor bone marrow cells play a role in the prevention of accelerated graft rejection induced by semi-allogeneic spleen cells in transplantation.
de Moraes LV; Bueno V; Marguti I; Martins GA; Vallochi AL; Yamamoto GL; Panajotopoulos N; Mengel JO; Rizzo LV
Transpl Immunol; 2008 Feb; 18(4):330-7. PubMed ID: 18158119
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts.
Yoon IH; Choi SE; Kim YH; Yang SH; Park JH; Park CS; Kim Y; Kim JS; Kim SJ; Simpson E; Park CG
Transplantation; 2008 Nov; 86(10):1352-60. PubMed ID: 19034003
[TBL] [Abstract][Full Text] [Related]
10. Delayed skin allograft rejection following matrix membrane pretreatment.
Stubenitsky BM; Brasile L; Rebellato LM; Hawinkels H; Haisch C; Kon M
J Plast Reconstr Aesthet Surg; 2009 Apr; 62(4):520-5. PubMed ID: 18194877
[TBL] [Abstract][Full Text] [Related]
11. Determination of the functional status of alloreactive T cells by interferon-gamma kinetics.
Kwun J; Knechtle SJ; Hu H
Transplantation; 2006 Feb; 81(4):590-8. PubMed ID: 16495808
[TBL] [Abstract][Full Text] [Related]
12. The influence of tissue culture on corneal immunogenicity.
Gabric N; Dekaris I; Suman L; Karaman Z; Mravicic I
Exp Eye Res; 1999 Mar; 68(3):277-82. PubMed ID: 10079135
[TBL] [Abstract][Full Text] [Related]
13. Prolongation of alloskin graft survival by catalytic scavengers of reactive oxygen species.
Tocco G; Illigens BM; Malfroy B; Benichou G
Cell Immunol; 2006 Jun; 241(2):59-65. PubMed ID: 16970930
[TBL] [Abstract][Full Text] [Related]
14. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.
Lan YY; Tokita D; Wang Z; Wang HC; Zhan J; Brinkmann V; Thomson AW
Transpl Immunol; 2008 Nov; 20(1-2):88-94. PubMed ID: 18694829
[TBL] [Abstract][Full Text] [Related]
15. Survival of skin allografts is prolonged in mice with a dominant-negative H-Ras.
Funeshima-Fuji N; Fujino M; Kimura H; Takahara S; Nakayama T; Ezaki T; Li XK
Transpl Immunol; 2008 Feb; 18(4):302-6. PubMed ID: 18158115
[TBL] [Abstract][Full Text] [Related]
16. The novel IMPDH inhibitor VX-497 prolongs skin graft survival and improves graft versus host disease in mice.
Decker CJ; Heiser AD; Chaturvedi PR; Faust TJ; Ku G; Moseley S; Nimmesgern E
Drugs Exp Clin Res; 2001; 27(3):89-95. PubMed ID: 11447770
[TBL] [Abstract][Full Text] [Related]
17. Lymph node removal enhances corneal graft survival in mice at high risk of rejection.
Plsková J; Holán V; Filipec M; Forrester JV
BMC Ophthalmol; 2004 Mar; 4():3. PubMed ID: 15038832
[TBL] [Abstract][Full Text] [Related]
18. Effect of CD200 and CD200R1 expression within tissue grafts on increased graft survival in allogeneic recipients.
Yu K; Chen Z; Gorczynski R
Immunol Lett; 2013 Jan; 149(1-2):1-8. PubMed ID: 23178470
[TBL] [Abstract][Full Text] [Related]
19. Platonin improves survival of skin allografts.
Cheng SP; Lee JJ; Chi CW; Chang KM; Chen YJ
J Surg Res; 2010 Nov; 164(1):146-54. PubMed ID: 19766247
[TBL] [Abstract][Full Text] [Related]
20. Free bone graft attenuates acute rejection and in combination with cyclosporin a leads to indefinite cardiac allograft survival.
Wang H; Ge W; Arp J; Zassoko R; Liu W; Ichim TE; Jiang J; Jevnikar AM; Garcia B
J Immunol; 2009 May; 182(10):5970-81. PubMed ID: 19414748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
